Influence of vitamin D supplementation and the vaginal microenvironment on human papillomavirus infection
Abstract
Full Text:
PDFReferences
Thun MJ, DeLancey JO, Center MM, Jemal A and Ward EM.
The global burden of cancer: priorities for prevention.
Carcinogenesis. 2010; 31(1):100-10.
Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, Jemal
A, Yu XQ and He J. Cancer statistics in China, 2015.
CA Cancer J Clin. 2016; 66(2):115-32.
Wright TC, Jr., Cox JT, Massad LS, Carlson J, Twiggs LB
and Wilkinson EJ. 2001 consensus guidelines for the
management of women with cervical intraepithelial
neoplasia. Am J Obstet Gynecol. 2003; 189(1):295-
Chao X, Sun T, Wang S, Tan X, Fan Q, Shi H, Zhu L and
Lang J. Research of the potential biomarkers in
vaginal microbiome for persistent high-risk human
papillomavirus infection. Ann Transl Med. 2020;
(4):100.
Mitra A, MacIntyre DA, Marchesi JR, Lee YS, Bennett PR
and Kyrgiou M. The vaginal microbiota, human
papillomavirus infection and cervical intraepithelial
neoplasia: what do we know and where are we going
next? Microbiome. 2016; 4(1):58.
Przybylski M, Pruski D, Millert-Kalinska S, Zmaczynski A,
Baran R, Horbaczewska A, Jach R and Zaborowska L.Remission of HPV infection after LEEP-conization -
a retrospective study. Ginekol Pol. 2022;
Petrillo M, Dessole M, Tinacci E, Saderi L, Muresu N,
Capobianco G, Cossu A, Dessole S, Sotgiu G and
Piana A. Efficacy of HPV Vaccination in Women
Receiving LEEP for Cervical Dysplasia: A Single
Institution's Experience. Vaccines (Basel). 2020; 8(1)
Aryanian Z, Balighi K, Goodarzi A, Afshar ZM, Hatami P.
Vitamin D and HPV infection: Clinical pearls. J
Cosmet Dermatol. 2024;
Chu TW, Jhao JY, Lin TJ, Lin TW, Wang CL, Chang HS, Liu
LC and Chang CC. Vitamin D in gynecological
diseases. J Chin Med Assoc. 2021; 84(11):1054-1059.
Wilson Westmark NL, Sroussi H, Tamayo I and Villa A.
Vitamin D status in patients with oropharyngeal
cancer: Association with HPV status and prognosis.
Oral Dis. 2023; 29(2):542-546.
Brestovac B, Wong ME, Costantino PS and Groth D. A rapid
DNA extraction method suitable for human
papillomavirus detection. J Med Virol. 2014;
(4):653-7.
Smith JH. Bethesda 2001. Cytopathology : official journal
of the British Society for Clinical Cytology. 2002;
(1):4-10.
Ndizeye Z, Menon S, Van Geertruyden JP, Sauvaget C,
Jacquemyn Y, Bogers JP, Benoy I and Vanden Broeck
D. Performance of OncoE6(TM) Cervical Test in
detecting cervical precancer lesions in HIV-positive
women attending an HIV clinic in Bujumbura,
Burundi: a cross-sectional study. BMJ Open. 2019;
(9):e029088.
Tabassi Z, Bagheri S, Samimi M, Gilasi HR, Bahmani F,
Chamani M and Asemi Z. Clinical and Metabolic
Response to Vitamin D Supplementation in
Endometrial Hyperplasia: a Randomized, DoubleBlind, Placebo-Controlled Trial. Horm Cancer. 2017;
(3):185-195.
Razzaghi R, Pourbagheri H, Momen-Heravi M, Bahmani F,
Shadi J, Soleimani Z and Asemi Z. The effects of
vitamin D supplementation on wound healing and
metabolic status in patients with diabetic foot ulcer: A
randomized, double-blind, placebo-controlled trial. J
Diabetes Complications. 2017; 31(4):766-772.
Weston G, Dombrowski C, Harvey MJ, Iftner T, Kyrgiou M,
Founta C and Adams EJ. Use of the Aptima mRNA
high-risk human papillomavirus (HR-HPV) assay
compared to a DNA HR-HPV assay in the English
cervical screening programme: a decision tree model
based economic evaluation. BMJ Open. 2020;
(3):e031303.
Vos RA, Pasmans H, Tymchenko L, Janga-Jansen AVA,
Baboe-Kalpoe S, Hulshof K, de Melker HE and van
der Klis FRM. High seroprevalence of multiple highrisk human papillomavirus types among the general
population of Bonaire, St. Eustatius and Saba,
Caribbean Netherlands. Vaccine. 2020; 38(13):2816-
Castle PE, Varallo JE, Bertram MM, Ratshaa B, Kitheka M
and Rammipi K. High-risk human papillomavirus
prevalence in self-collected cervicovaginal specimens
from human immunodeficiency virus (HIV)-negative
women and women living with HIV living in
Botswana. PLoS One. 2020; 15(2):e0229086.
Pańczyszyn A, Boniewska-Bernacka E and Głąb G.
Telomere length in leukocytes and cervical smears of
women with high-risk human papillomavirus (HR
HPV) infection. Taiwan J Obstet Gynecol. 2020;
(1):51-55.
Manley KM, Luker R and Park C. An audit of liquid-based
cytology samples reported as high-risk human
papillomavirus and borderline nuclear change in
endocervical cells. Cytopathology. 2020; 31(2):130-
Sangpichai S, Patarapadungkit N, Pientong C,
Ekalaksananan T, Chaiwiriyakul S, Thongbor R,
Sirivech P, Jangsiriwitayakorn P and
Triamwittayanon T. Chlamydia Trachomatis
Infection in High-Risk Human Papillomavirus Based
on Cervical Cytology Specimen. Asian Pac J Cancer
Prev. 2019; 20(12):3843-3847.
Zhao S, Zhao XL, Hu SY, Wang Y, Remila R, Xu XQ, Duan
XZ, Chen F, Zhang X and Zhao FH. [Comparison of
high-risk human papillomavirus infection rate and
genotype distribution between Han and Mongolian
women]. Zhonghua Liu Xing Bing Xue Za Zhi. 2019;
(11):1439-1444.
Cao M, Wang Y, Wang D, Duan Y, Hong W, Zhang N, Shah
W, Wang Y and Chen H. Increased High-Risk Human
Papillomavirus Viral Load Is Associated With
Immunosuppressed Microenvironment and Predicts a
Worse Long-Term Survival in Cervical Cancer
Patients. Am J Clin Pathol. 2020; 153(4):502-512.
Kang HJ, Chu KB, Kim MJ, Park H, Jin H, Lee SH, Moon
EK and Quan FS. Evaluation of CpG-ODNAdjuvanted Toxoplasma Gondii Virus-Like Particle
Vaccine upon One, Two, and Three Immunizations.
Pharmaceutics. 2020; 12(10)
Nikouyan N, Farhadi A, Gorzin AA, Geramizadeh B,
Okhovat MA, Seyyedi N, Dehbidi GR, Ranjbaran R
and Behzad-Behbahani A. A fluorometric
hybridization assay for detecting and genotyping
high-risk human papillomavirus 16 and 18 in archival
tissues of cervical specimens. Braz J Microbiol. 2020;
(1):161-168.
Chan PK, Cheung TH, Li WH, Yu MY, Chan MY, Yim SF,
Ho WC, Yeung AC, Ho KM and Ng HK. Attribution
of human papillomavirus types to cervical
intraepithelial neoplasia and invasive cancers in
Southern China. Int J Cancer. 2012; 131(3):692-705.
Kyrgiou M, Mitra A and Moscicki AB. Does the vaginal
microbiota play a role in the development of cervical
cancer? Transl Res. 2017; 179:168-182.
Troja C, Hoofnagle AN, Szpiro A, Stern JE, Lin J and Winer
RL. Understanding the Role of Emerging Vitamin D
Biomarkers on Short-term Persistence of High-Risk
Human Papillomavirus Infection Among Mid-Adult
Women. J Infect Dis. 2021; 224(1):123-132.
Brewczyński A, Jabłońska B, Mrowiec S, Składowski K and
Rutkowski T. Nutritional Support in Head and Neck
Radiotherapy Patients Considering HPV Status.
Nutrients. 2020; 13(1)
Saroul N, Martraix C, Mulliez A, Cassagnes L, Puechmaille
M, Bernadach M, Biau J, Walrand S and Lapeyre M.
[Impact of HPV status on nutritional status during
radio chemotherapy for oropharyngeal cancer].
Cancer Radiother. 2023; 27(1):42-49.
Sutandyo N, Brahma B and Ifandriani R. Pretreatment
nutritional status, HPV infection, and tumor
infiltrating lymphocyte as prognostic predictors in
patients with head and neck squamous cell carcinoma
after chemotherapy. J Cancer Res Ther. 2022;
(Supplement):S177-s181.
Lee DY and Lee TS. Associations between metabolic
syndrome and gynecologic cancer. Obstet Gynecol
Sci. 2020; 63(3):215-224.
Zhou Z-W, Long H-Z, Cheng Y, Luo H-Y, Wen D-D and
Gao L-C. From Microbiome to Inflammation: The
Key Drivers of Cervical Cancer. Frontiers in
Microbiology. 2021; 12
Refbacks
- There are currently no refbacks.






